miércoles, 3 de julio de 2024
AHRQ Commemorates 35 Years as an Independent Science Agency
AHRQ Commemorates 35 Years as an Independent Science Agency: Blog announces the 35th anniversary of the Agency for Healthcare Research and Quality (AHRQ).
Continuing a 35-Year History, AHRQ Pursues Vital Pathways to Improve Patient Care
https://www.ahrq.gov/news/blog/ahrqviews/35-year-history.html
Arm in Arm with AcademyHealth, AHRQ is Poised to Build on Successes in Health Services Research
Arm in Arm with AcademyHealth, AHRQ is Poised to Build on Successes in Health Services Research: Third and final blog post about commemorating AHRQ's 35th anniversary year.
Enhancing Surgical Team Communication: SOPS® and TeamSTEPPS® in Action (Webcast)
Enhancing Surgical Team Communication: SOPS® and TeamSTEPPS® in Action (Webcast): This webcast will provide background on AHRQ’s Surveys on Patient Safety Culture® (SOPS®) program, the TeamSTEPPS 3.0 team training curriculum, and how the use of TeamSTEPPS improves SOPS scores.
Public Workshop – Food and Drug Administration/National Institutes of Health Joint Workshop: Developing Implanted Brain-Computer Interface Clinical Outcome Assessments to Demonstrate Benefit, September 19 and 20, 2024 SEPTEMBER 19 - 20, 2024Public Workshop – Food and Drug Administration/National Institutes of Health Joint Workshop: Developing Implanted Brain-Computer Interface Clinical Outcome Assessments to Demonstrate Benefit, September 19 and 20, 2024 SEPTEMBER 19 - 20, 2024
martes, 2 de julio de 2024
CAHPS Research Meetings: Upcoming: Patient-Reported Experience and Outcome Measures (PREMs and PROMs) in Research and Clinical Practice (September 17, 2024) Date: September 17, 2024 Time: 11:00 a.m. - 4:00 p.m. ET
CAHPS Research Meetings: AHRQ occasionally hosts research meetings that bring together researchers, subject matter experts and key stakeholders to focus on specific topics of interest related to CAHPS surveys.
Climate Change Indicators in the United States: Fifth Edition
https://www.epa.gov/climate-indicators/climate-change-indicators-united-states-fifth-edition
EPA Releases Updated Climate Indicators Report Showing How Climate Change is Impacting People’s Health and the Environment
WASHINGTON — Today, July 2, the United States Environmental Protection Agency released the Fifth Edition of Climate Change Indicators in the United States. The report highlights new data showing the continuing and far-reaching impacts of climate change on the people and environment of the United States. New to the report this year are an indicator on Marine Heat Waves (showing trends related to multi-day high ocean temperatures) and a feature on Heat-Related Workplace Deaths.
“EPA’s Climate Change Indicators report is an authoritative resource of how the climate crisis is affecting every American right now and with increasing intensity,” said EPA Administrator Michael S. Regan. “Extreme heat, flooding, and wildfires have become more common, harming human health, threatening livelihoods, and causing costly damage. Regular updates to the data in the Climate Indicators website and report help us track these unprecedented changes so we are better informed in our shared work to confront the crisis.”
The Fifth Edition presents highlights from a subset of EPA’s total of 57 indicators, which include historical data and observed trends related to either the causes or effects of climate change. The report explores the interconnected nature of observed changes in climate with chapters thematically organized around Greenhouse Gases, Heat on the Rise, Extreme Events, Water Resources at Risk, Changing Seasons, Ocean Impacts, Rising Seas, and Alaska’s Warming Climate. Since publishing the first edition in 2010, EPA has maintained an up-to-date online resource of climate change indicators and regularly released updated publications that present the latest data.
EPA partners with more than 50 data contributors from various U.S. and international government agencies, academic institutions, and other organizations to compile these key indicators of climate change. EPA’s indicators show multiple lines of compelling evidence that climate change is increasingly affecting people’s health, society, and ecosystems in numerous ways.
lunes, 1 de julio de 2024
Medication Without Harm - How Digital Healthcare Tools Can Support Providers and Improve Patient Safety Event Date: July 24, 2024 | 2:30pm – 4:00pm ET
https://digital.ahrq.gov/national-webinars/medication-without-harm-how-digital-healthcare-tools-can-support-providers-and
Medication Without Harm - How Digital Healthcare Tools Can Support Providers and Improve Patient Safety
AHRQ will host a free webinar on July 24, 2024, from 2:30 – 4:00 pm ET where an expert panel of speakers will share their research about how quality improvement approaches and digital healthcare interventions such as clinical decision support tools are reducing medication errors, improving provider effectiveness, and enhancing patient safety in a variety of clinical care settings.
ASTHMAXcel PRO Mobile Application to Support Asthma Chronic Disease Management
https://digital.ahrq.gov/program-overview/research-stories/asthmaxcel-pro-mobile-application-support-asthma-chronic-disease-management
Supporting Asthma Chronic Disease Management
A mobile application designed to facilitate asthma self-management and shared decision making through patient-reported outcomes can improve care, asthma control, and knowledge, as well as decrease healthcare utilization.
Care Transitions App for Patients with Multiple Chronic Conditions
https://digital.ahrq.gov/ahrq-funded-projects/care-transitions-app-patients-multiple-chronic-conditions#nav-research-story
Improving Care Transitions for Patients with Multiple Chronic Conditions with an App
A patient-facing app simplifying the information patients and caregivers receive has the potential to better engage patients and families in their healthcare post-discharge and reduce adverse events.
Rheumatology Informatics System for Effectiveness Patient-Reported Outcome (RISE PRO) Dissemination Project
https://digital.ahrq.gov/ahrq-funded-projects/rheumatology-informatics-system-effectiveness-patient-reported-outcome-rise-pro#nav-research-story
Harnessing Patient-Reported Outcomes to Improve Rheumatoid Arthritis Care
Development of a toolkit to facilitate the scale and spread of using patient-reported outcomes among rheumatoid arthritis patients fills an existing gap in national resources to provide support to rheumatologists.
Inform Shared Decision Making with Advanced Bayesian Causal Inference to Improve Quality of Pediatric Rheumatology CareInform Shared Decision Making with Advanced Bayesian Causal Inference to Improve Quality of Pediatric Rheumatology Care
https://digital.ahrq.gov/ahrq-funded-projects/inform-shared-decision-making-advanced-bayesian-causal-inference-improve
Description: This research will design, develop, implement, and evaluate the Patient Centered Adaptive Treatment Strategies (PCATS) juvenile idiopathic arthritis (JIA) tool called “PCATS.JIA.” a shared decision-making tool for monitoring and treatment of polyarticular juvenile idiopathic arthritis in children.
Principal Investigator: Morgan, Esi M., Huang, Bin
Project Dates: April 01, 2023 to March 31, 2028
A Decision Support Tool for the Discontinuation of Disease Modifying Therapies in Multiple Sclerosis
https://digital.ahrq.gov/ahrq-funded-projects/decision-support-tool-discontinuation-disease-modifying-therapies-multiple
Description: This research will develop, validate, and evaluate a decision support tool using a machine learning algorithm to standardize the approach to discontinuing disease-modifying therapies for multiple sclerosis.
Principal Investigator: McGinley, Marisa
Project Dates: August 01, 2023 to July 31, 2028
RAPS Convergence 2024 to Feature Session on Accelerating Breakthrough Device Commercialization — Led by HPM Medical Device Regulatory Expert Adrienne Lenz Thursday, September 19, 2024, 4:30 PM – 5:30 PM
RAPS Convergence 2024 is set to host a must-attend session on CDRH’s Total Product Life Cycle Advisory Program (TAP), promising attendees an exclusive insight into a pioneering initiative aimed at improving the medical device commercialization landscape.
Thursday, September 19, 2024, 4:30 PM – 5:30 PM
https://www.thefdalawblog.com/2024/07/raps-convergence-2024-to-feature-session-on-accelerating-breakthrough-device-commercialization-led-by-hpm-medical-device-regulatory-expert-adrienne-lenz/?utm_source=rss&utm_medium=rss&utm_campaign=raps-convergence-2024-to-feature-session-on-accelerating-breakthrough-device-commercialization-led-by-hpm-medical-device-regulatory-expert-adrienne-lenz
Suscribirse a:
Entradas (Atom)
.png)
